Synthaverse S.A. Logo

Synthaverse S.A.

BML | WAR

Overview

Corporate Details

ISIN(s):
PLBMDLB00018 (+3 more)
LEI:
259400OWZM67D079S374
Country:
Poland
Address:
LUBLIN UNIWERSYTECKA 10, 20-029 LUBLIN
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Synthaverse S.A. is a pharmaceutical and biotechnology company with a history dating back to 1944. The company develops, manufactures, and sells medicinal products (both prescription and OTC), medical devices, and laboratory reagents. Its portfolio focuses on treatments in the areas of oncology, hematology, and immunology, with products sold in approximately 50 countries. Key brands include Onko BCG, a drug for bladder cancer, and the BCG 10 anti-tuberculosis vaccine, for which the company is the sole supplier in Poland. Synthaverse emphasizes the use of its own proprietary technologies and close cooperation with scientific centers to drive research and innovation.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Synthaverse S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-01 11:16
Declaration of Voting Results & Voting Rights Announcements
zal01_ESPI-wykaz-akcjonariuszy-posiadajacych-co-najmniej-5-glosow-na-NWZA-31.07…
Polish 142.0 KB
2025-08-01 11:16
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Nadzwyczajnym Walnym…
Polish 351 bytes
2025-08-01 11:10
Post-Annual General Meeting Information
zal01_UCHWALY_PODJETE_NWZA_31.07.2025.pdf
Polish 247.2 KB
2025-08-01 11:10
Declaration of Voting Results & Voting Rights Announcements
Treść uchwał podjętych przez Nadzwyczajne Walne Zgromadzenie Emitenta w dniu 31…
Polish 1.1 KB
2025-07-14 17:47
Board/Management Information
Rozszerzenie składu zarządu Spółki Synthaverse S.A. - Content (PL)
Polish 4.9 KB
2025-07-09 17:51
Major Shareholding Notification
zal01_FormularzF.pdf
Polish 89.4 KB
2025-07-09 17:51
Major Shareholding Notification
Znaczne pakiety akcji - zmiana w ogólnej liczbie głosów - Content (PL)
Polish 669 bytes
2025-07-08 17:47
Major Shareholding Notification
zal01_FormularzA_ponizej_5_proc.pdf
Polish 77.8 KB
2025-07-08 17:47
Major Shareholding Notification
zal02_FormularzA_powyzej_5_proc.pdf
Polish 77.8 KB
2025-07-08 17:47
Major Shareholding Notification
Znaczne pakiety akcji - zmiana w ogólnej liczbie głosów - Content (PL)
Polish 529 bytes
2025-07-08 16:12
Major Shareholding Notification
zal01_Zawiadomienie_o_stanie_posiadania.pdf
Polish 374.5 KB
2025-07-08 16:12
Major Shareholding Notification
Znaczne pakiety akcji - zmiana w ogólnej liczbie głosów. - Content (PL)
Polish 481 bytes
2025-07-08 09:37
Major Shareholding Notification
zal01_FormularzA.pdf
Polish 78.7 KB
2025-07-08 09:37
Major Shareholding Notification
Znaczne pakiety akcji - zmiana w ogólnej liczbie głosów. - Content (PL)
Polish 537 bytes
2025-07-05 15:54
Regulatory News Service
zal03_pdf_852875.pdf
Polish 4.5 KB

Automate Your Workflow. Get a real-time feed of all Synthaverse S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Synthaverse S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Orion Oyj Logo
Develops and markets human/vet pharmaceuticals and APIs, focusing on oncology and pain management.
Finland ORNAV
Otsuka Holdings Co., Ltd. Logo Japan 4578
Oxford Biomedica PLC Logo
A CDMO for cell & gene therapy, providing end-to-end viral vector development & manufacturing.
United Kingdom OXB
PAION AG Logo
Developed innovative drugs for hospital sedation, anesthesia, and critical care.
Germany PA8
PeptiDream Inc. Logo Japan 4587
PEPTONIC Medical AB Logo
Develops clinically proven self-care products and diagnostics for women's intimate health.
Sweden PMED
Perseus Proteomics Inc. Logo Japan 4882
Pharma Mar S.A. Logo
Develops and commercializes marine-derived oncology treatments for rare cancers.
Spain PHM
Pharmanutra Logo
Develops science-backed nutraceuticals & pharmaceuticals for nutritional & joint health.
Italy PHN
PharmaSGP Holding SE Logo
Develops & distributes natural, pharmacy-exclusive OTC drugs for chronic conditions in Europe.
Germany PSG